Injectable nanoparticulate olanzapine formulations
First Claim
Patent Images
1. An injectable nanoparticulate olanzapine composition comprising:
- (a) olanzapine nanoparticles having an effective average particle size that results in a therapeutic efficacy of about one week or greater;
(b) at least one surface stabilizer; and
(c) a pharmaceutically acceptable carrier, wherein said effective average particle size is between about 300 nm and about 5000 nm.
9 Assignments
0 Petitions
Accused Products
Abstract
Described are injectable formulations of nanoparticulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise nanoparticulate olanzapine.
96 Citations
17 Claims
-
1. An injectable nanoparticulate olanzapine composition comprising:
- (a) olanzapine nanoparticles having an effective average particle size that results in a therapeutic efficacy of about one week or greater;
(b) at least one surface stabilizer; and
(c) a pharmaceutically acceptable carrier, wherein said effective average particle size is between about 300 nm and about 5000 nm. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
- (a) olanzapine nanoparticles having an effective average particle size that results in a therapeutic efficacy of about one week or greater;
Specification